Phase 3b/4 Safety Trial of Nivolumab Combined with Ipilimumab in Subjects with Previously Untreated, Advanced or Metastatic RCC

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
Bristol-Myers Squibb

Protocol Number
CA209-920

To Learn More Call
201-510-0910